Cite

HARVARD Citation

    Griffiths, K. et al. (2019). Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4. MAbs. 11 (7), pp. 1331-1340. [Online]. 
  
Back to record